Bionoid Pharma Stock Price on November 6, 2024
| BINP Stock | USD 0.27 0.02 8.00% |
If you're considering investing in Bionoid Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Bionoid Pharma stands at 0.27, as last reported on the 13th of December 2024, with the highest price reaching 0.27 and the lowest price hitting 0.27 during the day. Bionoid Pharma is out of control given 3 months investment horizon. Bionoid Pharma secures Sharpe Ratio (or Efficiency) of 0.11, which signifies that the company had a 0.11% return per unit of risk over the last 3 months. We were able to interpolate twenty different technical indicators, which can help you to evaluate if expected returns of 2.23% are justified by taking the suggested risk. Use Bionoid Pharma Mean Deviation of 8.17, standard deviation of 19.14, and Risk Adjusted Performance of 0.097 to evaluate company specific risk that cannot be diversified away.
Bionoid Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Bionoid |
Sharpe Ratio = 0.1142
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | BINP | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 19.56 actual daily | 96 96% of assets are less volatile |
Expected Return
| 2.23 actual daily | 44 56% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Bionoid Pharma is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bionoid Pharma by adding it to a well-diversified portfolio.
Bionoid Pharma Valuation on November 6, 2024
It is possible to determine the worth of Bionoid Pharma on a given historical date. On November 6, 2024 Bionoid was worth 0.1 at the beginning of the trading date compared to the closed value of 0.1. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Bionoid Pharma pink sheet. Still, in general, we apply an absolute valuation method to find Bionoid Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bionoid Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Bionoid Pharma's related companies.
| Open | High | Low | Close | Volume | |
| 0.25 | 0.25 | 0.25 | 0.25 | 1.00 | |
11/06/2024 | 0.10 | 0.10 | 0.10 | 0.10 | 4,498 |
| 0.05 | 0.25 | 0.05 | 0.15 | 9,229 |
| Backtest Bionoid Pharma | | | Bionoid Pharma History | | | Bionoid Pharma Valuation | Previous | Next |
Bionoid Pharma Trading Date Momentum on November 6, 2024
| On November 07 2024 Bionoid Pharma was traded for 0.15 at the closing time. The top price for the day was 0.25 and the lowest listed price was 0.05 . The trading volume for the day was 9.2 K. The trading history from November 7, 2024 was a factor to the next trading day price gain. The overall trading delta against the next closing price was 50.00% . The overall trading delta against the current closing price is 50.00% . |
Bionoid Pharma Fundamentals Correlations and Trends
By evaluating Bionoid Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Bionoid Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Bionoid financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Bionoid Pharma Pink Sheet history
Bionoid Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Bionoid is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Bionoid Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Bionoid Pharma stock prices may prove useful in developing a viable investing in Bionoid Pharma
Bionoid Pharma Inc. engages in the hemp cultivation business. Bionoid Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 5 people.
Bionoid Pharma Pink Sheet Technical Analysis
Bionoid Pharma technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Bionoid Pharma Period Price Range
Low | December 13, 2024
| High |
0.00 | 0.00 |
Bionoid Pharma cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Bionoid Pharma December 13, 2024 Market Strength
Market strength indicators help investors to evaluate how Bionoid Pharma pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bionoid Pharma shares will generate the highest return on investment. By undertsting and applying Bionoid Pharma pink sheet market strength indicators, traders can identify Bionoid Pharma entry and exit signals to maximize returns
Bionoid Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Bionoid Pharma's price direction in advance. Along with the technical and fundamental analysis of Bionoid Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Bionoid to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.097 | |||
| Jensen Alpha | 2.09 | |||
| Total Risk Alpha | (0.39) | |||
| Treynor Ratio | 1.15 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Bionoid Pink Sheet Analysis
When running Bionoid Pharma's price analysis, check to measure Bionoid Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionoid Pharma is operating at the current time. Most of Bionoid Pharma's value examination focuses on studying past and present price action to predict the probability of Bionoid Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionoid Pharma's price. Additionally, you may evaluate how the addition of Bionoid Pharma to your portfolios can decrease your overall portfolio volatility.